Stoke Therapeutics Inc. logo

Stoke Therapeutics Inc. (0GT)

Market Open
8 Dec, 07:09
26. 20
0
0%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-2.44 Eps
26.2
Previous Close
Day Range
26.2 26.2
Year Range
5.2 32.6
Want to track 0GT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
11 Nov 2025
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
3 Nov 2025
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
5 Aug 2025
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
5 May 2025
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
24 Mar 2025
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
5 Nov 2024
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
5 Aug 2024
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
5 Jun 2024
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
2 May 2024
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
25 Mar 2024
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
4 Mar 2024
-
Cons. EPS
-
EPS
Stoke Therapeutics Inc. logo
0GT Stoke Therapeutics Inc.
13 Nov 2023
-
Cons. EPS
-
EPS

0GT Earnings Reports FAQ

What is the earnings per share (EPS) for 0GT?

The current EPS is -2.44.

What is the company's earnings growth rate?

Stoke Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Stoke Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Stoke Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0GT at this time, as Stoke Therapeutics Inc has no recent EPS data to calculate it.